As of 2025-07-19, the Relative Valuation of Mesa Laboratories Inc (MLAB) is 16.05 USD. This relative valuation is based on P/E multiples. With the latest stock price at 70.05 USD, the upside of Mesa Laboratories Inc based on Relative Valuation is -77.1%.
The range of the Relative Valuation is (8.04) - 46.00 USD.
| Range | Selected | |
| Trailing P/E multiples | 26.6x - 37.6x | 34.9x |
| Forward P/E multiples | 33.1x - 36.8x | 34.2x |
| Fair Price | (8.04) - 46.00 | 16.05 |
| Upside | -111.5% - -34.3% | -77.1% |
| Date | P/E |
| 2025-07-17 | -252.94 |
| 2025-07-16 | -261.32 |
| 2025-07-15 | -256.50 |
| 2025-07-14 | -273.97 |
| 2025-07-11 | -285.76 |
| 2025-07-10 | -298.62 |
| 2025-07-09 | -300.21 |
| 2025-07-08 | -304.28 |
| 2025-07-07 | -307.32 |
| 2025-07-03 | -341.91 |
| 2025-07-02 | -332.75 |
| 2025-07-01 | -323.09 |
| 2025-06-30 | -311.55 |
| 2025-06-27 | -326.27 |
| 2025-06-26 | -318.63 |
| 2025-06-25 | -324.02 |
| 2025-06-24 | -326.00 |
| 2025-06-23 | -323.75 |
| 2025-06-20 | -316.84 |
| 2025-06-18 | -307.49 |
| 2025-06-17 | -306.63 |
| 2025-06-16 | -317.74 |
| 2025-06-13 | -321.08 |
| 2025-06-12 | -330.30 |
| 2025-06-11 | -345.58 |
| 2025-06-10 | -345.05 |
| 2025-06-09 | -340.12 |
| 2025-06-06 | -343.86 |
| 2025-06-05 | -329.97 |
| 2025-06-04 | -333.74 |
| 2025-06-03 | -331.06 |
| 2025-06-02 | -323.92 |
| 2025-05-30 | -332.72 |
| 2025-05-29 | -345.99 |
| 2025-05-28 | -340.82 |
| 2025-05-27 | -374.31 |
| 2025-05-23 | -363.24 |
| 2025-05-22 | -367.10 |
| 2025-05-21 | -370.25 |
| 2025-05-20 | -381.32 |
| 2025-05-19 | -392.00 |
| 2025-05-16 | -404.80 |
| 2025-05-15 | -401.26 |
| 2025-05-14 | -397.13 |
| 2025-05-13 | -419.75 |
| 2025-05-12 | -423.25 |
| 2025-05-09 | -409.50 |
| 2025-05-08 | -415.12 |
| 2025-05-07 | -397.76 |
| 2025-05-06 | -390.12 |